http://www.biospace.comBioSpace RSS GeneratorSat, 18 May 2013 11:57:08 GMT20http://rss.biospace.com/images/BSPLogo.gifhttp://www.BioSpace.com/news.aspx?SectionId=1Copyright (C) 2011http://www.popularmechanics.com/science/health/breakthroughs/transistor-could-help-to-restore-the-sensation-of-touch-15397568Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>A new type of transistor could enable smarter touchscreens, artificial skin that "feels," and prosthetic limbs that send sensory feedback to amputees. Years after a motorcycle accident left him paralyzed from...Fri, 17 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130517005126&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has presented key pre-clinical proof-of-concept data from its RNAi...Fri, 17 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130517005074&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it has called for redemption of its outstanding $400.0 million in aggregate principal amount of 3.35% Convertible...Fri, 17 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297117&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">WALTHAM, Mass.</span>, <span class"xn-chron">May 16, 2013</span> /PRNewswire/ -- <b>Alere Inc.</b> (NYSE: ALR), a global leader in enabling individuals...Fri, 17 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130516005879&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>BOSTON--(BUSINESS WIRE)--Today the Biogen Idec Foundation announced a $250,000 grant to East End House to develop, implement and evaluate an interactive out-of-school-time (OST) genetics program for middle school...Fri, 17 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130517005158&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company will be...Fri, 17 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297055&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">CANTON, Mass.</span>, <span class"xn-chron">May 17, 2013</span> /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today...Fri, 17 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130516006059&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria...Fri, 17 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/17/548085/10033178/en/Abiomed-to-Present-at-UBS-Global-Health-Care-Conference.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>DANVERS, Mass., May 17, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor Relations...Fri, 17 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297052&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">NATICK, Mass.</span>, <span class"xn-chron">May 17, 2013</span> /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate at the...Fri, 17 May 2013 12:00:00 AM GMThttp://www.dailymarkets.com/stock/2013/05/16/inspiremd-to-announce-six-month-results-from-the-mguard%E2%84%A2-embolic-protection-stent-eps-master-trial-at-europcr/Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>BOSTON and TEL AVIV, Israel, May 16, 2013 /PRNewswire/ <br><br>InspireMD, Inc. (InspireMD or the Company) (NYSE MKT: NSPR), the leader in embolic protection stents, today announced a robust schedule...Fri, 17 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297096&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">NATICK, Mass.</span>, <span class"xn-chron">May 17, 2013</span> /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in Digestive...Fri, 17 May 2013 12:00:00 AM GMThttp://www.xconomy.com/boston/2013/05/16/atlas-leans-on-amgen-novartis-to-build-new-crop-of-startups/Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Fresh off raising $265 million to bankroll its ninth fund, Atlas Venture has forged strategic partnerships with Amgen and Novartis to help supply the bigger companies with innovative new drug candidates. The...Thu, 16 May 2013 12:00:00 AM GMThttp://zeenews.india.com/news/health/healthy-eating/sugar-sweetened-beverages-linked-to-increased-kidney-stone-risk_21959.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Twenty percent of American males and 10 percent of American females will experience a kidney stone at some point in their lifetime. Often, these patients will be advised to drink more fluids as a way to prevent...Thu, 16 May 2013 12:00:00 AM GMThttp://zeenews.india.com/news/health/health-news/marijuana-users-have-better-blood-sugar-control_21961.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Regular marijuana use is associated with favorable indices related to diabetic control, say investigators. They found that current marijuana users had significantly lower fasting insulin and were less likely...Thu, 16 May 2013 12:00:00 AM GMThttp://in.reuters.com/article/2013/05/15/us-cancer-gilead-idINBRE94E1BL20130515Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's...Thu, 16 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297000&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>LEXINGTON, Mass., May 16, 2013 Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, today announced that data from a clinical study of...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130516005396&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative medicine, today confirmed that the vision of a patient enrolled in a clinical investigation...Thu, 16 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296932&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">NATICK, Mass.</span>, <span class"xn-chron">May 15, 2013</span> /PRNewswire/ -- The first patient has been enrolled in a clinical investigation evaluating...Thu, 16 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/16/547733/10033062/en/Pacific-Biosciences-and-Sage-Science-Announce-Co-Marketing-Partnership.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>MENLO PARK, Calif. and BEVERLY, Mass., May 16, 2013 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB), provider of the PacBio RS II DNA Sequencing System, and Sage Science, a developer...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130516005632&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>CAMBRIDGE, Mass.--(BUSINESS WIRE)--NinePoint Medical, Inc., an emerging leader in the development of medical devices for advanced optical imaging, today announced the commercial launch of its proprietary NvisionVLE...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130516005849&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it is expanding its OneSource Laboratory Services...Thu, 16 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297007&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>May 16, 2013 -- CMA Microdialysis is proud to announce the release of the NEW CMA 4004 Syringe Pump</p><p>Ideal for Microdialysis applications</p><p> Easy to use intuitive touch screen user interface...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130515006969&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced that additional data from the Phase 3 TIVO-1 trial (TIvozanib Versus sOrafenib in 1st line advanced RCC) of investigational agent...Thu, 16 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296835&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">BURLINGTON, Mass.</span>, <span class"xn-chron">May 15, 2013</span> /PRNewswire/ -- LeMaitre Vascular (Nasdaq: LMAT) announced today that JJ Pellegrino...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130516005879&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>BOSTON--(BUSINESS WIRE)--Today the Biogen Idec Foundation announced a $250,000 grant to East End House to develop, implement and evaluate an interactive out-of-school-time (OST) genetics program for middle school...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130516005264&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporations continued strong growth earned the company a place on Boston Business Journals list of the 100 largest private companies in the New England area. PHT Corporation...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130516005192&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company is the...Thu, 16 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/16/547715/10032995/en/ZIOPHARM-Announces-Presentation-of-Promising-Nonclinical-and-Phase-I-Study-Results-of-Ad-RTS-IL-12-in-Advanced-Melanoma-at-ASGCT-16th-Annual-Meeting.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>BOSTON, May 16, 2013 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced promising results from nonclinical and Phase 1 studies in advanced melanoma using Ad-RTS-IL-12, a novel DNA-based...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130516005313&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Sunovion Pharmaceuticals Inc. (Sunovion) announced today that the company will present six posters at the 2013 American Thoracic Society (ATS) International Conference, three of which pertain to a recently completed...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.7455870ed7fce121adda3242e6908a0c/index.jsp?ndmViewId=news_view&newsId=20130516005079&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today announced that the Company's management team will present...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130516005678&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>LEXINGTON, Mass.--(BUSINESS WIRE)--Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, today announced that data from a clinical study...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130516005048&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>BURLINGTON, Mass.--(BUSINESS WIRE)--To mark the second annual Hereditary Angioedema (HAE) Day, Dyax Corp. today announced the launch of HAE Allies, a new program recognizing the physicians, nurses, family members...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130515006985&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced scheduled presentations at the 2013 American Society for Clinical Oncology (ASCO) Annual Meeting, which is taking place May 31 June 4 in Chicago...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130515007005&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that Phase 1 clinical data for IPI-145, its potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, will be presented at...Thu, 16 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/16/547743/10033072/en/TESARO-Announces-Presentation-of-Niraparib-Clinical-Data-at-the-2013-ASCO-Annual-Meeting.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>WALTHAM, Mass., May 16, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, today announced that final results from a Phase 1 trial of niraparib, an inhibitor...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130515006878&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Eutropics Pharmaceuticals Inc. announced today that Eutropics and The University of Texas MD Anderson Cancer Center will present results from a clinical study employing Eutropics proprietary PraediCare Dx ...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130515006363&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that clinical data on Iclusig (ponatinib) and AP26113, its investigational inhibitor of anaplastic lymphoma kinase (ALK), epidermal growth factor receptor...Thu, 16 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/15/547580/10032982/en/ZIOPHARM-Announces-Poster-Presentation-at-the-2013-American-Society-for-Clinical-Oncology-ASCO-Annual-Meeting.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>BOSTON, May 15, 2013 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that Gerald P. Linette, MD, PhD, of the Washington University School of Medicine, will present updated clinical...Thu, 16 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/15/547579/10032961/en/Karyopharm-Therapeutics-to-Present-Clinical-Data-on-Selective-Inhibitor-of-Nuclear-Export-SINE-KPT-330-at-2013-ASCO-Annual-Meeting.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>NATICK, Mass., May 15, 2013 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc., a leader in the new field of nuclear transport modulators, announced that clinical data for its lead drug candidate, KPT-330, in...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130516005678&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, today announced that data from a clinical study of PRM-151 in patients with idiopathic...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130515006172&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 2013 UBS Global Healthcare Conference on Wednesday, May...Thu, 16 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130516005733&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Waters Corporation (NYSE:WAT) John Ornell, Chief Financial Officer, will speak to the investment community at the UBS 2013 Global Healthcare Conference at the Sheraton New York Hotel in New York City on Tuesday...Thu, 16 May 2013 12:00:00 AM GMThttp://www.bizjournals.com/boston/blog/bioflash/2013/05/daktari-diagnostics-collects-7m-in.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Daktari Diagnostics Inc. has landed another round of funding. The Cambridge, Mass.-based developer of diagnostic tests for HIV, hepatitis and tuberculosis secured $7 million in equity financing, according to...Wed, 15 May 2013 12:00:00 AM GMThttp://www.scienceworldreport.com/articles/6847/20130514/clay-grow-bone-synthetic-silicate-nanoplatelets-induce-stem-cells-make.htmStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>In new research published online May 13, 2013 in Advanced Materials, researchers from Brigham and Women's Hospital (BWH) are the first to report that synthetic silicate nanoplatelets (also known as layered...Wed, 15 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296685&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><b>Tokai Pharmaceuticals Announces $35.5 Million Series E Financing</b><br><br>CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments...Wed, 15 May 2013 12:00:00 AM GMTStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its Board of...Wed, 15 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296808&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Lille (France), Boston (Massachusetts, United States), May 15, 2013 GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical company at the forefront of drug discovery and development, focusing on...Wed, 15 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296818&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div id"releaseBody"><p>WALTHAM, MA--(Marketwired - May 15, 2013) - <a href"http://www.thermedical.com/">Thermedical&#174;</a>, a medical equipment company developing new tissue-ablation therapies...Wed, 15 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace2/template.PAGE/menuitem.ce58e8202d51f40bfcb16f10c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130514006866&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Accellent Inc. (the Company or Accellent), a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal first quarter ended March 31, 2013. <br><br>While financial results...Wed, 15 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130514005220&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Interleukin Genetics, Inc. (OTCQB: ILIU) today issued financial and operational results for the first quarter ended March 31, 2013. <br><br>Revenue for the quarter ended March 31, 2013 was $487,000, compared...Wed, 15 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130515005347&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today reported financial results for the quarter ended March 31, 2013. <br><br>Our next objective in Ideras autoimmune disease program is to initiate a Phase...Wed, 15 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130515005230&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today reported financial results for the quarter ended March...Wed, 15 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296786&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">BOSTON</span>, <span class"xn-chron">May 15, 2013</span> /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY), a provider of quality innovative healthcare...Wed, 15 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.b30484b92e958b11adda3242e6908a0c/index.jsp?ndmViewId=news_view&newsId=20130515005286&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, joins the International MPS Network and others...Wed, 15 May 2013 12:00:00 AM GMThttp://www.eurekalert.org/pub_releases/2013-05/bmj-lct051013.phpStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Living close to a major road may impair kidney functionitself a risk factor for heart disease and strokeand so help contribute to the known impact of air pollution on cardiovascular risk, suggests research...Tue, 14 May 2013 12:00:00 AM GMTStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><font size"3"><b>Analogic Corporation Announces Plan to Streamline Its Global Business</font></b><br><br>Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology...Tue, 14 May 2013 12:00:00 AM GMThttp://web.mit.edu/newsoffice/2013/study-ids-key-protein-for-cell-death-0514.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>When cells suffer too much DNA damage, they are usually forced to undergo programmed cell death, or apoptosis. However, cancer cells often ignore these signals, flourishing even after chemotherapy drugs have...Tue, 14 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296529&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><b>Third Rock Ventures Expands and Strengthens Team</b><br><br>BOSTON & SAN FRANCISCO, May 14, 2013 (BUSINESS WIRE) -- Third Rock Ventures, LLC, a venture capital firm focused on building healthcare companies...Tue, 14 May 2013 12:00:00 AM GMThttp://www.bizjournals.com/boston/blog/bioflash/2013/05/karyopharm-therapeutics-gets-205m.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Clinical-stage biopharma Karyopharm Therapeutics has secured $20.5 million of a $60 million offering. Its the second round of funding received by the Natick, Mass. developer of cancer- and inflammation-targeting...Tue, 14 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296629&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> <div class"xn-content"><p><span class"xn-location">WALTHAM, Mass.</span>, <span class"xn-chron">May 14, 2013</span> /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a late-stage oncology company focused on...Tue, 14 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296544&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> <div class"xn-content"><p><span class"xn-location">WALTHAM, Mass.</span>, <span class"xn-chron">May 13, 2013</span> /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company") announced today that it intends...Tue, 14 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296568&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> <div class"xn-content"><p><span class"xn-location">WALTHAM, Mass.</span>, <span class"xn-chron">May 13, 2013</span> /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company") announced today that, in connection...Tue, 14 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130513006383&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced financial results for its third quarter ended...Tue, 14 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.b30484b92e958b11adda3242e6908a0c/index.jsp?ndmViewId=news_view&newsId=20130513006383&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced financial results for its third quarter ended...Tue, 14 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130513006515&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today reported financial results for the first quarter ended March 31, 2013. <br><br>"Following our successful initial public offering in March 2013, Tetraphase...Tue, 14 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.b30484b92e958b11adda3242e6908a0c/index.jsp?ndmViewId=news_view&newsId=20130513006515&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today reported financial results for the first quarter ended March 31, 2013. <br><br>"Following our successful initial public offering in March 2013, Tetraphase...Tue, 14 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130514005341&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the appointment of John Jack Green as Chief Financial Officer...Tue, 14 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296631&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">ACTON, Mass.</span>, <span class"xn-chron">May 14, 2013</span> /PRNewswire/ -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of...Tue, 14 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130514005447&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) announced today they will present linaclotide-related data during Digestive Disease Week 2013 in Orlando, Fla., May ...Tue, 14 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130514005203&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sagentia, a global innovation, technology and product development company, and MIT Technology Review are partnering to co-host a special event to present and discuss the ...Tue, 14 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130513006464&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the UBS Global Healthcare Conference...Tue, 14 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130514005131&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the UBS Global Healthcare Conference on May 21, 2013, at 12:30 p.m. ET in New York. <br><br>A live webcast of Infinity's presentation will...Tue, 14 May 2013 12:00:00 AM GMThttp://www.sciencedaily.com/releases/2013/05/130512140603.htmStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Experiments at Johns Hopkins have unearthed clues about which protein signaling molecules are allowed into hollow, hair-like "antennae," called cilia, that alert cells to critical changes in their environments...Mon, 13 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296330&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><b>Dyax Corp. Announces $30 Million Offering</b><br><br>BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that it has priced a registered direct offering with RA Capital Management...Mon, 13 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130513005482&newsLang=enWESTON, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) announced today that the U.S. Food and Drug Administration (FDA) has accepted the companys Biologics License Application (BLA) for the marketing approval of ELOCTATE (recombinant factor VIII Fc fusion protein) for the treatment of hemophilia A. ELOCTATE is the first hemophilia A product candidate in a new class of long-lasting clotting factor...Mon, 13 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296410&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> <div class"xn-content"><p /><p /><p /><p><span class"xn-location">NATICK, Mass.</span>, <span class"xn-chron">May 10, 2013</span> /PRNewswire/ -- New data from 100,438 patients with Boston Scientific Corporation...Mon, 13 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/10/546334/10032456/en/BG-Medicine-Inc-Reports-Inducement-Grant-Under-NASDAQ-Listing-Rule-5635-c-4.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>WALTHAM, Mass., May 10, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, announced today that the...Mon, 13 May 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/05/13/546609/10032528/en/Merrimack-Reports-First-Quarter-2013-Financial-Results.htmlStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>CAMBRIDGE, Mass., May 13, 2013 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK), a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired...Mon, 13 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130510005786&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Spire Corporation ("Spire") (Nasdaq: SPIR), a global solar company providing capital equipment and turn-key manufacturing lines to produce photovoltaic ("PV") modules and providing engineering, procurement and...Mon, 13 May 2013 12:00:00 AM GMT